Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1112 |
---|---|
Product Name | Anti-Human CD40 Recombinant Antibody(Lucatumumab) |
Molecular Name | Lucatumumab |
Alias | Anti-CD40 Recombinant Antibody, Research Grade Lucatumumab |
CAS Number | 903512-50-5 |
Target | CD40[Homo sapiens] |
Isotype | IgG1 Kappa |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | FCM, IP, ELISA, Neut, FuncS, IF, ICC |
Buffer | PBS, pH7.5 |
Background | Lucatumumab (CHIR 12.12 or HCD122) is a human monoclonal antibody against CD40 development of which was discontinued by Novartis in 2013 after it was investigated for the treatment of various types of cancer like multiple myeloma and follicular lymphoma. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |